Therefore, we pointed out that FFAR4 deficiency has abolished the effect of n-3 PUFAs on improving the diversity and composition of the gut microbiota, characterized by a decrease in the abundance of genera that contribute to NAFLD prevention while increasing the abundance of genera that promote NAFLD. The gene discussed is FFAR4; the disease is metabolic dysfunction-associated steatotic liver disease.